Evaluating hospital at home: patient satisfaction and costs
Evaluating the impact of a Hospital-in-the-Home Service on patient satisfaction and costs requires a comparison that captures both the experience of care and the resources used to deliver it. In Brisbane, home-based acute care can keep a clinically appropriate patient out of a public hospital while bringing nursing, medicines and clinical oversight into familiar surroundings.
The value of the model cannot be inferred from bed-day savings alone. Australian teams often call this model HITH, but local programmes differ in scope: some treat infections, chronic disease flare-ups or post-operative needs, while others provide early discharge and home nursing. A credible evaluation must define the service, eligible population and comparator before attributing changes in experience or expenditure.
Why hospital at home matters
Queensland’s geography makes a flexible home model especially relevant. In Brisbane, an acutely unwell patient may live closer to relatives, community pharmacies and transport than to the treating hospital; across regional and remote areas, travel can be burdensome and specialist access thinner. A home visit can preserve face-to-face care where telehealth alone is inadequate, although digital access and suitable space must be checked rather than assumed.
Patient satisfaction often reflects convenience, confidence and continuity, but it can also expose hidden burdens. Families may provide meals, medication supervision or overnight help, and some patients cannot safely be treated at home without carer support or a suitable bathroom. Queensland partnerships are important for joining clinical and research expertise; Brisbane Diamantina Health Partners connects institutes, universities and health services to support this translation.
Designing a patient-centred evaluation
A strong evaluation should compare HITH with usual care for a clearly defined group. A prospective cohort with a matched ward-based group can estimate effects, while a randomised or stepped-wedge design offers stronger causal evidence where operationally feasible. Stratify or adjust for diagnosis, acuity, age, functional status, socioeconomic circumstances and prior hospital use; otherwise a favourable result may simply reflect healthier patients being referred home.
Measure experience at defined points, such as enrolment, discharge and 30 days, using a validated Australian patient survey alongside brief interviews. Separate satisfaction with access and staff from safety, symptom control, dignity and whether the person felt able to manage at home. Include carers because satisfaction can improve for the patient while workload rises for family members. Report response rates and missing data, and avoid treating a single overall score as the full outcome.
Measuring clinical and economic outcomes
Clinical measures protect against the risk that cheaper care is less effective. Track treatment success, complications, transfers to hospital, emergency department attendance, readmission within 30 days, mortality and changes in a patient-reported outcome such as quality of life. Prespecified safety thresholds should trigger review, particularly for sepsis, delirium, medication reactions or rapid deterioration at home.
For costs, build a complete episode view rather than comparing only the inpatient bed day. Include nursing visits, clinician time, travel, medicines, equipment, monitoring, pharmacy support, ambulance and emergency care, plus the value of any occupied hospital bed. Estimate informal care and lost work only in a separate societal analysis. Keep public-hospital and Medicare Benefit Schedule costs distinct because a Medicare rebate does not automatically fund every nursing or equipment component.
Compare total cost per completed episode and per clinically successful episode, then test how results change with plausible staffing, readmission and length-of-stay assumptions. Cost per quality-adjusted life year may help when health gains are measurable, but it should not replace plain-language estimates of additional cost and benefit. Recognised evaluation standards can guide the economic method and reporting.
Using real-world data responsibly
Real-world data can connect hospital, ambulance, pharmacy and Medicare claims records, but routine data reflects care as delivered, not a controlled trial. The real-world data guidance from Brisbane Diamantina Health Partners is a useful starting point for asking whether the data are fit for the question, how linkage is governed and how uncertainty will be communicated.
Governance should cover consent or lawful waiver, privacy, de-identification, access controls, retention and publication of small-cell results. Aboriginal and Torres Strait Islander data require community governance and culturally safe interpretation, not simply generic de-identification. Check duplicate deaths, delayed claims, changes in coding and missing outpatient encounters, and preserve a clear audit trail from source data to reported result.
Comparing home and hospital care
A fair comparison examines the care setting, patient experience, clinical pathway, cost structure, family burden and access rather than assuming one model is always superior.
| Measure | Hospital at home | Usual hospital care |
|---|---|---|
| Care setting | Familiar home environment with scheduled visits, medicines support and remote monitoring | Hospital ward with onsite teams and immediate access to diagnostic and treatment services |
| Patient experience | Convenience and continuity may improve satisfaction, while family workload and isolation can increase | Removes travel and home-care demands, but may involve prolonged admission, sleep disruption and loss of privacy |
| Clinical pathway | Designed for selected conditions with clear escalation criteria and rapid transfer pathways | Continuous observation and broad access to procedures, specialists and hospital diagnostics |
| Cost profile | Nursing intensity, travel, equipment and monitoring replace inpatient bed-day and overhead costs | Bed occupancy and staffing carry fixed costs even when the admission is brief or medically complex |
| Workforce and family | Community clinicians do more travelling and coordinating, potentially shifting work to carers | Hospital staff manage the episode directly, with discharge still requiring family preparation and support |
| Equity and access | Housing, digital connectivity, language, culture and carer availability affect who can safely participate | Provides a standard pathway for people who require continuous observation or an inpatient environment |
Interpretation depends on the eligible case mix. If HITH serves lower-acuity patients, lower readmissions may reflect selection; if carers decline admission, observed satisfaction may not transfer to the broader population. Presenting differences with confidence intervals and describing the pathway around each estimate will give decision-makers a more credible basis for scale-up.
Turning evidence into an actionable service
Decide whether to expand, redesign or stop using predefined criteria for clinical safety, access, equity, patient and carer experience, and total cost. Report results to participating patients and frontline clinicians in plain English, including limitations and the workload shifted to families. Publish the evaluation plan and a summary of outcomes so future services can compare methods rather than repeat weak baselines.
Start the next phase by convening patients, carers, clinicians, finance staff and data-governance partners; select one patient-reported outcome and one total-cost endpoint; and launch a time-limited, independently reviewed evaluation with clear referral, escalation and follow-up processes.
